Showing results 21 to 40 of 371
< previous
next >
Preview | Issue Date | Title | Author(s) |
| 2021 | Risk stratification and clinical utility of polygenic risk scores in ophthalmology | Qassim, A.; Souzeau, E.; Hollitt, G.; Hassall, M.M.; Siggs, O.M.; Craig, J.E. |
| 2021 | Cardiovascular disease predicts structural and functional progression in early glaucoma | Marshall, H.; Mullany, S.; Qassim, A.; Hassall, M.; Siggs, O.; Ridge, B.; Nguyen, T.; Awadalla, M.; Andrew, N.; Healey, P.; Agar, A.; Galanopoulos, A.; Hewitt, A.; Macgregor, S.; Graham, S.; Mills, R.; Landers, J.; Casson, R.; Craig, J. |
| 2021 | Retinal energy metabolism in health and glaucoma | Casson, R.J.; Chidlow, G.; Crowston, J.G.; Williams, P.A.; Wood, J.P.M. |
| 2021 | Subthreshold Nanosecond Laser in Age-Related Macular Degeneration: Observational Extension Study of the LEAD Clinical Trial | Guymer, R.H.; Chen, F.K.; Hodgson, L.A.B.; Caruso, E.; Harper, C.A.; Wickremashinghe, S.S.; Cohn, A.C.; Sivarajah, P.; Tindill, N.; Luu, C.D.; Wu, Z.; Al-Qureshi, S.; Busija, L.; Louis, D.; Harper, C.; Wickremasinghe, S.; Van Wijngaarden, P.; Lim, L.; Durkin, S.; Runciman, J.; et al. |
| 2021 | Multimodal retinal imaging and microperimetry reveal a novel phenotype and potential trial end points in CRB1-associated retinopathies | Roshandel, D.; Thompson, J.A.; Heath Jeffery, R.C.; Sampson, D.M.; Chelva, E.; Mc Laren, T.L.; Lamey, T.M.; De Roach, J.N.; Durkin, S.R.; Chen, F.K. |
| 2021 | Screening rates for diabetic retinopathy among Aboriginal and Torres Strait Islander women with hyperglycaemia in pregnancy: the PANDORA cohort study | Rohit, A.; Roulston, T.; Henderson, T.; Lee, I.L.; Webster, V.; McIntyre, H.D.; Connors, C.; Brown, A.; Shaw, J.E.; Maple-Brown, L.J.; Barr, E.L.M. |
| 2021 | Prevalence of eye conditions, utilization of eye health care services, and ophthalmic medications after entering residential aged care in Australia | Khadka, J.; Ratcliffe, J.; Caughey, G.E.; Wesselingh, S.L.; Inacio, M.C. |
| 2021 | Childhood and early-onset glaucoma classification and genetic profile in a large Australasian disease registry | Knight, L.S.W.; Ruddle, J.B.; Taranath, D.A.; Goldberg, I.; Smith, J.E.H.; Gole, G.; Chiang, M.Y.; Willett, F.; D’Mellow, G.; Breen, J.; Qassim, A.; Mullany, S.; Elder, J.E.; Vincent, A.L.; Staffieri, S.E.; Kearns, L.S.; Mackey, D.A.; Luu, S.; Siggs, O.M.; Souzeau, E.; et al. |
| 2020 | Hawkmoth lamina monopolar cells act as dynamic spatial filters to optimize vision at different light levels | Stöckl, A.L.; O'Carroll, D.C.; Warrant, E.J. |
| 2020 | Refractive index and temperature sensing with sagnac-mach zehnder hybrid fiber interferometer | Li, X.; Nguyen, V.; Ebendorff-Heidepriem, H.; Zhang, Y.; Warren-Smith, S.C.; Chinese Control and Decision Conference (CCDC) (22 Aug 2020 - 24 Aug 2020 : Hefei, China) |
| 2020 | Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin | Harder, J.M.; Guymer, C.; Wood, J.P.M.; Daskalaki, E.; Chidlow, G.; Zhang, C.; Balasubramanian, R.; Cardozo, B.H.; Foxworth, N.E.; Deering, K.E.; Ouellette, T.B.; Montgomery, C.; Wheelock, C.E.; Casson, R.J.; Williams, P.A.; John, S.W.M. |
| 2020 | Self-illuminating 'glow-in-the-dark' vitrectomy trocar cannulas: A pilot study | Chan, W.; Shields, M.; Casson, R.; Durkin, S. |
| 2020 | The genetic and clinical landscape of nanophthalmos and posterior microphthalmos in an Australian cohort | Siggs, O.M.; Awadalla, M.S.; Souzeau, E.; Staffieri, S.E.; Kearns, L.S.; Laurie, K.; Kuot, A.; Qassim, A.; Edwards, T.L.; Coote, M.A.; Mancel, E.; Walland, M.J.; Dondey, J.; Galanopoulous, A.; Casson, R.J.; Mills, R.A.; MacArthur, D.G.; Ruddle, J.B.; Burdon, K.P.; Craig, J.E. |
| 2020 | Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial | Hui, F.; Tang, J.; Williams, P.A.; McGuinness, M.B.; Hadoux, X.; Casson, R.J.; Coote, M.; Trounce, I.A.; Martin, K.R.; van Wijngaarden, P.; Crowston, J.G. |
| 2020 | Software for quantifying and batch processing images of brn3a and rbpms immunolabelled retinal ganglion cells in retinal wholemounts | Guymer, C.; Damp, L.; Chidlow, G.; Wood, J.; Tang, Y.F.; Casson, R. |
| 2020 | An intraocular pressure polygenic risk score stratifies multiple primary open-angle glaucoma parameters including treatment intensity | Qassim, A.; Souzeau, E.; Siggs, O.M.; Hassall, M.M.; Han, X.; Griffiths, H.L.; Frost, N.A.; Vallabh, N.A.; Kirwan, J.F.; Menon, G.; Cree, A.J.; Galanopoulos, A.; Agar, A.; Healey, P.R.; Graham, S.L.; Landers, J.; Casson, R.J.; Gharahkhani, P.; Willoughby, C.E.; Hewitt, A.W.; et al. |
| 2020 | Selective laser trabeculoplasty versus topical medication as initial glaucoma treatment: the glaucoma initial treatment study randomised clinical trial | Ang, G.S.; Fenwick, E.K.; Constantinou, M.; Gan, A.T.L.; Man, R.E.K.; Casson, R.J.; Finkelstein, E.A.; Goldberg, I.; Healey, P.R.; Pesudovs, K.; Sanmugasundram, S.; Xie, J.; McIntosh, R.; Jackson, J.; Wells, A.P.; White, A.; Martin, K.; Walland, M.J.; Crowston, J.G.; Lamoureux, E.L. |
| 2020 | Corneal stiffness parameters are predictive of structural and functional progression in glaucoma suspect eyes | Qassim, A.; Mullany, S.; Abedi, F.; Marshall, H.; Hassall, M.M.; Kolovos, A.; Knight, L.S.W.; Nguyen, T.; Awadalla, M.S.; Chappell, A.; Schulz, A.M.; Galanopoulos, A.; Agar, A.; Healey, P.R.; Hewitt, A.W.; Graham, S.L.; Landers, J.; Casson, R.J.; Siggs, O.M.; Craig, J.E. |
| 2020 | A polygenic risk score predicts intraocular pressure readings outside office hours and early morning spikes as measured by home tonometry | Qassim, A.; Mullany, S.; Awadalla, M.S.; Hassall, M.M.; Nguyen, T.; Marshall, H.; Kolovos, A.; Schulz, A.M.; Han, X.; Gharahkhani, P.; Galanopoulos, A.; Agar, A.; Healey, P.R.; Hewitt, A.W.; Landers, J.; Casson, R.J.; Graham, S.L.; MacGregor, S.; Souzeau, E.; Siggs, O.M.; et al. |
| 2020 | Is the eye a window to the brain in Sanfilippo syndrome? | Beard, H.; Chidlow, G.; Neumann, D.; Nazri, N.; Douglass, M.; Trim, P.J.; Snel, M.F.; Casson, R.J.; Hemsley, K.M. |